Our laboratory is dedicated to identifying vulnerabilities in MDS and leukemia stem cells to discover new therapeutic targets. We are committed to translating these discoveries into innovative treatments, with the goal of moving promising therapies from the laboratory to clinical trials.
Geovana Santos is a PhD student in the Cancer Biology Program. Her research focuses on hematologic malignancies, particularly mechanisms of resistance in acute myeloid leukemia (AML) and how these mechanisms may contribute to the development of new therapeutic approaches. She earned a B.S. in Biomedical Sciences in Brazil and a graduate certificate in Clinical and Laboratory Hematology. Her previous research focused on the role of immunophenotyping in AML diagnosis and on the relationship between acute promyelocytic leukemia, disseminated intravascular coagulation, and advances in therapy. Prior to beginning her PhD, Geovana worked as a clinical laboratory analyst before transitioning to research as a temporary researcher at the University of Colorado Anschutz Medical Campus.